Terazosin hydrochloride is a quinazoline derivative and a competitive and orally activeα1-adrenoceptorantagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment^[1][2][3].

α1-adrenoceptor^[1]

Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells^[1].

Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm^[3].

423.89

C₁₉H₂₆ClN₅O₄

63074-08-8

盐酸特拉唑嗪

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.